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The short and long-term consequences of septic arthritis are uncertain. The purpose of this study was to 
determine the risk of mortality and adverse joint outcomes following septic arthritis of the native knee. 
METHODS 
A retrospective cohort study of patients undergoing knee washout for septic arthritis, without prior knee 
surgery, was performed utilising the national hospital database for England over twenty-years. The rate of 
mortality within 90-days, and the 1-year and long-term rate of adverse joint outcomes (arthrodesis, 
amputation, arthroplasty), was determined. The mortality rate for patients with a primary admitting 
diagnosis of septic arthritis (ICD-10; M00) was compared to cases where this was a secondary diagnosis. 
FINDINGS 
12132 patients were included (mean age 56.6 years; SD 24.9; 36% [4307/12132] female). Of the 10195 
(84%) cases with septic arthritis as the primary admitting diagnosis, the 90-day mortality rate was 7.05% 
(719/10195; 95% CI 6.56-7.57) rising to 22.69% (418/1842; 95% CI 20.80-24.68) for patients aged over 79-
years. Secondary septic arthritis was associated with adjusted odds for mortality of 2.10 (odds ratio; 95% CI 
1.79-2.46; p<0.001). The 1-year rate of arthrodesis was 0.13% (15/11393; 95% CI 0.07-0.22), amputation 
0.40% (46/11393; 95% CI 0.30-0.54), and arthroplasty 1.33% (152/11393; 95% CI 1.13-1.56). Within 15-
years, 8.76% (159/1816; 95% CI 7.50-10.15) underwent arthroplasty, corresponding to an annual risk of 
6.14 times (risk ratio; 95% CI 4.95-7.62; p<0.001) that of the general population. 
INTERPRETATION 
The consequences of septic knee arthritis (in a cohort of patients undergoing arthroscopic knee washout) are 
serious, with a 7% risk of mortality within 90-days, greater than 1% risk of adverse joint outcomes within 1-
year, and 9% risk of knee arthroplasty within 15-years. These findings highlight the potentially devastating 
outcomes associated with sepsis from musculoskeletal joint infection. 
 
FUNDING 
National Institute for Health Research (NIHR), UK 
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RESEARCH IN CONTEXT 
 
Evidence before this study 
A new search of Medline and Embase and Cochrane was performed to update that of a previous systematic 
review ((“pyogenic” OR “septic” OR “infectious”) AND “arthritis”; title, 01/01/2008 to 12/11/2018). 
Seventeen articles (from 2519 deduplicated results) reported more than 100 cases of suspected or proven 
septic arthritis in adults. No study was joint specific and most studies included patients with small joint 
infection, prior surgery or joint arthroplasty, and outcomes were reported at inconsistent periods of follow 
up. Several studies were limited to either older age-groups, patients with rheumatoid arthritis, a minority 
ethnic group, or reported results in less developed healthcare settings. The largest epidemiological study 
(40,433 care episodes) identified episodes of care for patients with a diagnosis code of septic arthritis (non-
specific for joint) from United States emergency care admissions and reported mortality based on inpatient 
discharge destination. This study reported the lowest mortality rate of 0.77% (311/40433; 95% CI 0.69 to 
0.86; 1 study). Combined with the other studies, the overall mortality rate in all study patients was 1.56% 
(804/51527; 95% CI 1.46 to 1.67; 17 studies), but rates exceeding 5% were reported in 13 studies and 
exceeding 10% in 5 studies. A poor joint outcome (functional or arthroplasty) was reported in 9.00% of 
cases (97/1078; 95% CI 7.36 to 10.87; 6 studies) but this was inconsistently defined. There is therefore 
considerable uncertainty around these outcomes. No cohort has been limited to the most commonly affected 
joint, the knee, or excluded patients with prior knee surgery such are total joint arthroplasty which is likely 
to change outcomes. The rates of objective, native joint, adverse outcomes, as defined by arthrodesis, 
amputation, or arthroplasty, are particularly poorly defined. 
 
Added value of this study 
This study of 12,132 patients was limited to patients undergoing arthroscopic washout of the knee joint for a 
diagnosis of septic arthritis. Patients with a history of prior knee surgery were excluded. This study reports a 
higher rate of mortality (8.94% at 90-days; 1084/12132; 95% CI 8.43-9.46) than previously reported studies 
which had highly heterogenous inclusion criteria. In comparison to patients with a primary admitting 
diagnosis of septic arthritis, patients where this was a secondary diagnosis had significantly greater odds of 
mortality (odds ratio 2.10; 95% CI 1.79 to 2.46; p<0.001) and older patients also had greater odds of 
mortality (odds ratio 1.38 per 5-years; 95% CI 1.34 to 1.42; p<0.001). A reduction in the rate of mortality 
was observed over the twenty-year study period (odds ratio 0.89 per 5-years; 95% CI 0.83 to 0.96; p=0.002). 
Objective, joint specific, adverse outcomes (arthrodesis, amputation, arthroplasty) are reported at 1-year 
(0.13%, 0.40%, 1.33% respectively). The long-term, mortality-adjusted, rate of joint survival (not 
undergoing knee arthroplasty) is reported for the first time. The odds of mortality and hazard of arthroplasty 
are reported, stratified by patient factors including age, sex, comorbidity, deprivation, diabetes, ethnicity, 
and prior joint disease.  
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Implications of all the available evidence 
These findings confirm that septic arthritis of the knee (in a cohort of patients undergoing arthroscopic knee 
washout) is associated with a high rate of mortality and morbidity. The rate of mortality is considerably 
higher than reported in many other studies that included small joint infections alongside septic arthritis of 
large joints such as the knee. In the long-term, 8.76% (159/1816; 95% CI 7.50-10.15) patients underwent 
arthroplasty within 15-years, corresponding to an annual risk that was 6.14 times (risk ratio; 95% CI 4.95 to 
7.62; p<0.001) that of the general population. These findings will be informative to patients and clinicians 
and should drive further work to improve the short- and long-term outcomes of patients presenting with this 







Septic arthritis is an uncommon condition but has been considered a medical emergency due to potential life 
and limb threatening consequences.1,2 Rates of mortality as high as 10-15%,3–8 osteomyelitis in 8%,8 and a 
subjective poor outcome in 20-30% of cases have been reported.3,6,8–10 The true rate of adverse outcomes has 
remained uncertain as previous studies have had a number of limitations, such as heterogenous inclusion 
criteria and inconsistent reporting of outcomes. No study has been joint specific and most studies included 
patients with small joint infection, prior surgery or joint arthroplasty, and outcomes were reported at 
inconsistent periods of follow up. Several studies were limited to either older age-groups, patients with 
rheumatoid arthritis, a minority ethnic group, or reported results in less developed healthcare settings. The 
knee is the joint most commonly affected by septic arthritis,6,8 but no study has been limited to, or focused 
on, patients with septic arthritis of the knee and the true rate of mortality and long-term adverse joint 
outcomes in these patients is unknown. 
 
The purpose of this study was to determine the short- and long-term consequences of septic arthritis of the 
knee joint in patients without a history of prior knee surgery. A cohort of patients undergoing arthroscopic 
knee washout for septic arthritis was identified over a twenty-year period. The rate of mortality within 90-
days and rate of adverse joint outcomes in the short- and long-term was determined with stratification by 
patient-factors including age, sex, prior comorbidity or joint disease, deprivation, ethnicity, and according to 







We performed a longitudinal cohort study utilising the national healthcare records for England, UK. Data 
was provided by NHS Digital (application DARS-NIC-68703). These data, the national Hospital Episode 
Statistics (HES), contain a record of all episodes of care delivered by NHS hospitals in England.11 Records 
are submitted prospectively by hospitals to claim for reimbursement of care provided, including surgical 
procedures. HES includes episodes of care delivered in treatment centres (including those in the independent 
sector) but funded by the NHS, episodes of care in England where patients are resident outside of England, 
and privately funded patients treated within NHS England hospitals. Data recorded includes patient age, sex, 
location of residence, primary and secondary diagnoses, procedures performed, and mortality data (deaths 
occurring either in hospital or in the community) from the Office for National Statistics (ONS).  
 
Participants and exposure 
All patients undergoing arthroscopic knee washout with a corresponding diagnosis of septic arthritis 
between 1 April 1997 and 31 March 2017 were eligible for inclusion. All HES records for these patients 
were extracted after identification using the recorded Classification of Surgical Operations and Procedures 
(OPCS-4) procedure code (W852) and ICD-10 diagnosis code for pyogenic arthritis (M00).12 Patients with a 
history of prior knee surgery to the same knee were excluded. 
 
Outcomes 
The primary outcome was mortality within 90-days. The primary outcome was compared for patients where 
septic arthritis was the primary admission diagnosis (ICD-10 M00) and for patients where this was a 
secondary diagnosis. The secondary outcomes were early and late adverse joint outcomes. Early adverse 
joint outcomes were defined as joint arthrodesis (fusion), amputation, or arthroplasty within 1-year. The 
long-term rate of arthroplasty in the same knee was compared to the estimated rate of arthroplasty in the 
national population (without a recorded history of septic arthritis in this cohort). Surgical outcomes were 
matched by knee laterality (side). Temporal trends in the rate of washout for septic arthritis over the twenty-
year period were also analysed. 
 
Statistical analysis 
Demographic data were summarised with descriptive statistics. The age- and sex-standardised temporal 
trends in the population rate of arthroscopic washout for septic arthritis was calculated using census data 
from the ONS with 95% confidence intervals reported according to the methodology of the Association of 
Public Health Observatories (APHO).13 The absolute rates of 90-day mortality and 1-year adverse joint 
outcomes were reported as proportions with corresponding 95% confidence intervals (CI). Factors 
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associated with the odds of mortality within 90-days were calculated by logistic regression modelling, 
adjusting for primary versus secondary diagnosis, age group, sex, index of multiple deprivation (quintile 
derived from regional factors in England including average income, employment, education, housing, and 
crime; 1=least deprived area, 5=most deprived), ethnicity, modified Charlson comorbidity index (derived 
with maximum 5-year diagnosis code lookback period), prior osteoarthritis or rheumatoid osteoarthritis, 
diabetes, year of treatment, rurality, and ethnicity.14–17 
 
Long-term rates of knee arthroplasty were calculated as proportions of the cohort at 5-, 10-, or 15- years 
follow-up respectively. In addition, a mortality adjusted Kaplan-Meier survival analysis (survival was 
defined as not undergoing knee arthroplasty) was performed, stratified by patient age group. A Cox 
proportional-hazards model was used to calculate the unadjusted hazard for knee arthroplasty over time by 
each of the variables described above for the odds of mortality and adjusted including all these variables.  
 
The relative risk (risk ratio) of knee arthroplasty in comparison to the general population (without a history 
of joint washout for septic arthritis) was estimated for the year 2016-17. Nationally, all patients undergoing 
knee arthroplasty in 2016-17 were identified and the number of these patients with a recorded history of 
previous septic knee washout (in the prior years of HES data) versus those without this history made up the 
numerator for each respective population. The population denominators were the number of patients with a 
history of septic arthritis that had not undergone a knee arthroplasty prior to 2016-17 and the ONS mid-year 
population estimates less the septic arthritis population, respectively. 
 
Stata v15.1 (StataCorp, College Station, Texas, USA) was used to perform all analyses. All confidence 
intervals are reported at the 95% level with corresponding p-values where appropriate for the analyses. 
 
Role of the funding source 
The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full access to all the data in the study and had final 




Between April 1, 1997 and March 31, 2017, 15323 cases of arthroscopic knee washout for septic arthritis 
were identified of which 12132 procedures (12132 patients) were included (Figure 1).  
 
Demographics and trends 
The demographics of the cohort are summarised in Table 1. The mean age of the full cohort was 56.6 years 
(SD 24.9) and 35.5% (4307/12132) were female; for 10195 patients (84%; /12132), septic arthritis was the 
primary admission diagnosis.  
 
There was a greater proportion from the most deprived quintile of the population (2871/12132; 23.66%; 
95% CI 22.9 to 24.4) than expected for the whole population (p<0.001). 15.92% (1932/12132) of the cohort 
had a prior diagnosis of osteoarthritis and 6.28% (762/12132) rheumatoid arthritis. Just over half the cohort 
had no recorded comorbidities prior to treatment (6435/12132; 53.04%) and 15.90% (1929/12132) a 
diagnosis of diabetes. The median length of hospital stay was 13 days (interquartile range 6 to 26). 
 
There was a 44% increase in the rate of knee washout for septic arthritis over the twenty-year study period 
from 0.9/100,000 (95% CI 0.8 to 0.9) in 1997/97 to 1.3/100,000 (95% CI 1.2 to 1.4) in 2016/17. Over the 
study period, the age standardised intervention rate was 1.7/100,000 (95% CI 1.6 to 1.7) for men and 
0.8/100,000 (95% CI 0.8 to 0.8) for women.  
 
Mortality within 90-days 
The 90-day mortality rate for the whole cohort was 8.94% (1084/12132; 95% CI 8.43 to 9.46). For patients 
with a primary diagnosis of septic arthritis the mortality rate was 7.05% (719/10195; 95% CI 6.56 to 7.57) 
and for those with a secondary diagnosis of septic arthritis, the mortality rate was 18.84% (365/1937; 95% 
CI 17.12 to 20.66). 
 
In patients aged 40-59-years, the 90-day mortality rate was 1.84% (42/2284; 95% CI 1.33 to 2.48) in 
primary septic arthritis and 8.81% (31/352; 95% CI 6.06 to 12.27) in secondary cases. In those aged 60-79-
years the mortality rate was 7.39% (251/3396; 95% CI 6.53 to 8.32) in primary cases and 18.87% (140/742; 
95% CI 16.11 to 21.87) in secondary cases. In those aged over 79-years, the mortality rate was 22.69% 
(418/1842; 95% CI 20.80 to 24.68) in primary cases and 37.25% (190/510; 95% CI 33.05 to 41.61) in 
secondary cases (Table 1).  
 
Overall, a secondary diagnosis of septic arthritis was associated with 2.10 times greater adjusted odds of 
mortality (95% CI 1.79 to 2.46; p<0.001) (Table 2). The odds of mortality fell over the twenty-year study 
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period (adjusted odds ratio [OR] 0.89 per 5-years; 95% CI 0.83 to 0.96; p=0.002) (Table 2). The increased 
rate of mortality in older age groups corresponded to an odds ratio of 1.38 per 5-years of age (95% CI 1.34 
to 1.42; p<0.001). The odds of mortality were greater with increasing comorbidity index (OR 1.34 per 5-
units Charlson index; 95% CI 1.30 to 1.39; p<0.001) and, independently (excluding Charlson index from the 
model), with diabetes (OR 1.54; 95% CI 1.31 to 1.81; p<0.001). Lower odds of mortality were observed in 
patients with a diagnosis of osteoarthritis (OR 0.72; 95% CI 0.60 to 0.87; p=0.001). There was not, however, 
any association with sex, deprivation, rurality, or ethnicity (Table 2). 
 
Adverse joint outcomes within 1-year 
Of patients with at least 1-year of follow-up (n=11393), the rate of knee arthrodesis within 1-year was 
0.13% (15/11393; 95% CI 0.07 to 0.22), amputation 0.40% (46/11,393; 95% CI 0.30 to 0.54), and 
arthroplasty 1.33% (152/11393; 95% CI 1.13 to 1.56). These outcomes were observed at a similar rate 
across the cohort as summarised in Table 3. 
 
Long-term knee arthroplasty 
Of patients with the corresponding minimum period of follow-up, 5.62% (403/7170; 95% CI 5.10 to 6.18) 
underwent arthroplasty within 5-years, 6.68% (289/4326; 95% CI 5.95 to 7.47) within 10-years, and 8.76% 
(159/1816; 95% CI 7.50 to 10.15) within 15-years. The mortality-adjusted joint survival curve (not 
undergoing knee arthroplasty) by age-group, over 15-years, is shown in Figure 2. There was a greater hazard 
for arthroplasty in patients with a history of osteoarthritis (hazard ratio [HR] 2.50; 95% CI 2.09 to 3.00; 
p<0.001) and rheumatoid arthritis (HR 3.73; 95% CI 2.92 to 4.75; p<0.001) respectively, but lower in 
patients with a greater comorbidity index (HR 0.78 per 5-years; 95% CI 0.73 to 0.84; p<0.001) or, 
independently (excluding Charlson index from the model), diabetes (HR 0.77; 95% CI 0.61 to 0.98; 
p=0.032) (Table 4). 
 
The absolute and relative annual risk of knee arthroplasty in the population of patients with a history of 
septic arthritis in comparison to that estimated for the general population (with no recorded history of septic 
arthritis) is summarised in Table 5. The absolute annual risk of arthroplasty for patients over the age of 30-
years with a history of septic arthritis was 1.29% (95% CI 1.03 to 1.60) in comparison to 0.21% (95% CI 
0.21 to 0.21) for the general population. The annual risk, in 2016-17, for patients over the age of 30-years 
with a recorded history of knee washout for septic arthritis (in the preceding 20-years) was 6.14 times that of 
the general population estimate (risk ratio [RR]; 95% CI 4.95 to 7.62; p<0.001); rising to 27.25 times (RR; 





The consequences of septic knee arthritis are serious, with a 7% rate of mortality within 90-days, greater 
than 1% risk of adverse joint outcomes within 1-year, and 9% risk of knee arthroplasty within 15-years. The 
odds of mortality were double when septic arthritis was a secondary diagnosis for a hospital admission. 
These findings confirm septic arthritis of the knee to be a medical emergency with potentially severe 
consequences. Older patients and patients with medical comorbidities were at greatest risk of mortality, 
although the risk of mortality has fallen slightly over time. 
  
Comparison with other studies 
The incidence of suspected or proven, any joint, septic arthritis has been estimated at approximately 4-
10/100,000 patient-years.2,7,18 In 2016/17, the intervention rate for septic arthritis of the knee in our study 
was 1.3/100,000 patient-years. The lower rate is likely to reflect the fact that only the knee joint was 
considered although it may also partly reflect the high specificity of our approach to case identification. 
Previous studies have indicated a higher rate of septic arthritis in patients in disadvantaged groups.19,20 We 
observed similar findings, with the more deprived quintile of the English population being over-represented 
in the cohort at 24%. Patients with rheumatoid or skin disease have been shown to have a greater incidence 
of septic arthritis.2,8,20,21 Consistent with this, the proportion of our study cohort with a diagnosis of 
rheumatoid arthritis was 6%, in comparison to the expected population prevalence for rheumatoid arthritis of 
0.5-1.0%.8,20,21 Diabetes was also associated with septic arthritis in our cohort. The proportion of the cohort 
with diabetes was 16% in comparison to a population prevalence of approximately 5% in the United 
Kingdom.22 
 
Few studies have previously reported adverse outcomes associated with septic arthritis. Rates of mortality as 
high as 10-15% have been reported in some studies,6,8,20 but a lower rate of 2.7% was reported in a 
nationwide study in Iceland, and 0.77% in a study of emergency care admissions in the United States.18,23 
The rate of mortality in our study was between these estimates at 7.05% for patients with a primary 
admitting diagnosis of septic arthritis but rising to 18.84% in secondary diagnosis cases (16% of cohort). 
Overall, the adjusted odds of mortality in our cohort fell over the study period. A similar reduction in 
mortality over time has been observed for patients undergoing elective orthopaedic procedures.24,25 In the 
present cohort, the fall in mortality may reflect a similar general improvement in healthcare, and outcomes 
could also have been influenced, in part, by initiatives such as the international “Surviving Sepsis” campaign 
and guidelines first published in 2004.26,27  
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Older age and pre-existing joint disease have previously been shown to be poor prognostic factors for both 
joint outcome, mortality, and quality of life after an episode of septic arthritis in a small series of patients.6 
This may be due to lower functional reserve in these individuals. A greater odds of mortality was observed 
in patients with diabetes in the present cohort, as has been reported by other studies of surgical outcomes.28 
The largest age group in our study cohort was the 60-79-year age group and the 90-day mortality in the 
primary septic arthritis cohort in this age group was 7.39%, in comparison to 0.061% in the same period of 
time following arthroscopic partial meniscectomy, and 0.233% for the general population.25 A diagnosis of 
osteoarthritis was also found to be associated with mortality in our cohort. In the unadjusted model, 
osteoarthritis was associated with increased odds of mortality, as has been previously observed for all cause 
and disease specific longer term mortality rates in other cohorts.29,30 In previous series, this effect has been 
observed to be driven by higher rates of cardiac events, especially in those with a history of prior 
cardiovascular disease and osteoarthritis.29,30 In our cohort, the association was reversed after adjusting for 
age and comorbidity, but the reason for this unexpected observation is unclear. This could be a selection 
effect and, as the severity of the osteoarthritis is not recorded, one possibility is that this observation could 
be due to the presence of a healthier and more active age-matched patient group within the cohort being 
more likely to have a diagnosis of early osteoarthritis without other comorbidities, but the true reason for 
this finding is unknown. 
 
Long-term rates of osteoarthritis and knee replacement have been poorly defined but permanent loss of 
function has been reported by some studies in more than a quarter of septic arthritis patients.7,31–33 In one 
series, arthrodesis, amputation, or joint arthroplasty was reported in up to 23% (27/116) of cases within two-
years of septic arthritis.6 In another small study of patients developing septic arthritis after anterior cruciate 
ligament reconstruction, however, no evidence of progressive osteoarthritis was reported at 1 to 11 years.34 
In our study cohort, the rate of adverse joint outcomes was just over 1% at one-year, and by 15-years, 8.76% 
of patients had undergone knee arthroplasty. Patients with a pre-existing diagnosis of osteoarthritis or 
rheumatoid arthritis were at higher risk of undergoing subsequent arthroplasty, as would be expected. 
Patients with a greater comorbidity index were at lower risk of subsequent arthroplasty and this could be a 
result of patients with more comorbidities being less likely to either seek, or be able to access, arthroplasty.35 
 
Importantly, the annual rate of arthroplasty in patients with a history of knee washout for septic arthritis was 
six times greater than that of the general population without this history. There was also evidence of 
accelerated progression of osteoarthritis as evidenced by the rate of knee arthroplasty at a younger age being 
increased by up to twenty-seven times the annual rate of the general population for patients aged 40-49-
years. 
 
Strengths and limitations 
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This is the largest cohort of septic arthritis patients that has been reported, thereby increasing the precision 
and clinical importance of our findings. It is more comprehensive than all previous studies, reporting rates of 
90-day mortality and long-term rates of joint-loss, and comparing mortality outcomes for those with a 
primary admitting diagnosis of septic arthritis with those where this was secondary diagnosis. There are, 
however, some limitations. Our cohort only included operatively managed patients, undergoing arthroscopic 
washout; patients managed non-operatively, for example by serial aspirations and antibiotics, or with open 
washout were not included. Patients with suspected septic arthritis but a negative synovial aspirate are also 
highly likely to be underrepresented in our cohort, as these individuals will be less likely to undergo surgical 
treatment. The outcomes reported in this study cannot, therefore, be generalised to these patients or others 
managed with a non-operative treatment strategy. In some previous observational studies, patients 
undergoing operative management of septic arthritis had a worse outcome than those managed non-
operatively, but without randomised clinical evidence there is high likelihood of confounding by 
indication.8,36 In several studies, arthroscopic washout has been reported to have comparable results to both 
open washout and needle arthrocentesis.2,36–39 In one small cohort study in children, however, arthroscopic 
washout was found to be superior to open washout in clearing infection after the first treatment.40  
 
Patients with a prior history of knee surgery were excluded from our cohort. Approximately 1% of joint 
infections in children and 33-42% in adults are iatrogenic.7,18 The intention of this exclusion criterion was to 
create a more homogenous cohort with native knee joint septic osteoarthritis, undergoing arthroscopic 
washout, but it should be noted that our findings cannot be generalised to patients developing infection 
following previous surgery. Although patients had not undergone prior knee surgery, it is still possible that 
some of the infections were iatrogenic from, for example, intra-articular injections. In a cohort reported in 
Iceland, up to 18% of septic arthritis cases were detected following a history of joint injection, although 
other studies have reported lower rates between 2% and 6%.7,18,20  
 
Although our study was able to stratify analyses by a range of patient factors including demographics, pre-
existing medical and joint conditions, primary or secondary diagnosis, and regional deprivation, there are a 
number of unmeasured and potentially confounding factors that might increase or decrease risks. These 
include the duration of symptoms before diagnosis, the initiation and type of antibiotic therapy provided, 
serum inflammatory markers and microbiological findings. Other unmeasured patient factors include body 
mass index, smoking status, and medication history. Our study also relies on accurate data coding within the 
Hospital Episode Statistics database. The study cohort was identified by the procedure undertaken with a 
corresponding diagnosis of pyogenic arthritis. Previously, the Charlson comorbidity index as calculated 
from HES diagnosis fields, and records of serious vascular complications, have both been shown to correlate 
strongly with primary care records.41,42 The procedure and diagnosis code used for this cohort has not, 




In this study, septic arthritis (in a cohort of patients undergoing arthroscopic knee washout) was associated 
with a 7% rate of mortality within 90-days and a greater than 1% rate of adverse joint outcomes within 1-
year. Patients with a secondary diagnosis of septic arthritis were at considerably greater risk of mortality 
than those where this was the primary admission diagnosis. Within 15-years, 9% of patients underwent knee 
arthroplasty corresponding to approximately six times the annual rate of arthroplasty in the general 
population. A fall in the odds of mortality over the twenty-year study period was observed which may 
reflect improved treatment of patients with sepsis. Nevertheless, our findings indicate that septic arthritis is 
associated with a high rate of mortality and morbidity even after joint washout, highlighting the potentially 
devastating consequences of musculoskeletal joint infection and the need for an immediate and 
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TABLE 1:  
Demographics and 90-day Mortality for Patients with Septic Arthritis as the Primary Admission Diagnosis (ICD-10 
M00) versus a Secondary Diagnosis 
 
 Primary Admission Diagnosis Secondary Admission Diagnosis 
 Demographics 90-day Mortality Demographics 90-day Mortality 
 n % n % n % n % 
Total 10,195 100 719 7.05% (6.56, 7.57) 1,937 100 365 18.84% (17.12, 20.66) 
Sex  
Male 6,603 64.77 426 6.45% (5.87, 7.07) 1,222 63.09 210 17.18% (15.11, 19.42) 
Female 3,592 35.23 293 8.16% (7.28, 9.10) 715 36.91 155 21.68% (18.71, 24.88) 
Age Group  
< 20 1,110 10.89 1 0.09% (0.00, 0.50) 128 6.61 1 0.78% (0.02, 4.28) 
20 - 39 1,563 15.33 7 0.45% (0.18, 0.92) 205 10.58 3 1.46% (0.30, 4.22) 
40 - 59 2,284 22.4 42 1.84% (1.33, 2.48) 352 18.17 31 8.81% (6.06, 12.27) 
60 - 79 3,396 33.31 251 7.39% (6.53, 8.32) 742 38.31 140 18.87% (16.11, 21.87) 
80 + 1,842 18.07 418 22.69% (20.80, 24.68) 510 26.33 190 37.25% (33.05, 41.61) 
Charlson comorbidity index  
0 5,753 56.43 124 2.16% (1.80, 2.56) 682 35.21 42 6.16% (4.47, 8.23) 
1 - 15 3,134 30.74 257 8.20% (7.26, 9.22) 729 37.64 127 17.42% (14.74, 20.37) 
16 - 30 985 9.66 224 22.74% (20.16, 25.49) 367 18.95 127 34.60% (29.74, 39.72) 
31 - 50 323 3.17 114 35.29% (30.08, 40.78) 159 8.21 69 43.40% (35.57, 51.48) 
Prior joint disease  
No 7,984 78.31 517 6.48% (5.95, 7.04) 1,454 75.06 263 18.09% (16.14, 20.16) 
Osteoarthritis 1,592 15.62 138 8.67% (7.33, 10.16) 340 17.55 74 21.76% (17.49, 26.53) 
Rheumatoid arthritis 619 6.07 64 10.34% (8.05, 13.01) 143 7.38 28 19.58% (13.42, 27.04) 
Diabetes  
No 8,696 85.3 524 6.03% (5.53, 6.55) 1,507 77.8 263 17.45% (15.57, 19.46) 
Yes 1,499 14.7 195 13.01% (11.35, 14.82) 430 22.2 102 23.72% (19.78, 28.03) 
Index of multiple deprivation (quintile)  
1 = least deprived 1,731 17.52 139 8.03% (6.79, 9.41) 325 17.1 68 20.92% (16.63, 25.76) 
2 1,841 18.63 129 7.01% (5.88, 8.27) 364 19.15 80 21.98% (17.83, 26.59) 
3 1,955 19.79 152 7.77% (6.63, 9.05) 371 19.52 79 21.29% (17.24, 25.82) 
4 1,931 19.54 153 7.92% (6.76, 9.22) 392 20.62 61 15.56% (12.12, 19.54) 
5 = most deprived 2,422 24.51 138 5.70% (4.81, 6.70) 449 23.62 75 16.70% (13.37, 20.48) 
Missing 315    36    
Rurality  
Urban 7,911 79.72 556 7.03% (6.47, 7.61) 1,517 79.47 272 17.93% (16.03, 19.95) 
Rural 2,012 20.28 161 8.00% (6.85, 9.27) 392 20.53 92 23.47% (19.36, 27.98) 
Missing 272    28    
Ethnicity  
White 8,805 91.59 627 7.12% (6.59, 7.68) 1,673 90.58 322 19.25% (17.38, 21.22) 
Mixed 68 0.71 1 1.47% (0.04, 7.92) 15 0.81 2 13.33% (1.66, 40.46) 
Asian 396 4.12 15 3.79% (2.14, 6.17) 86 4.66 13 15.12% (8.30, 24.46) 
Black 258 2.68 9 3.49% (1.61, 6.52) 60 3.25 3 5.00% (1.04, 13.92) 
Other 87 0.90 3 3.45% (0.72, 9.75) 13 0.7 2 15.38% (1.92, 45.45) 
Missing 581    90    
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TABLE 2:  
Odds ratios for mortality (within 90 days of surgery) 
 
 Unadjusted Odds Mortality (90 day) Adjusted* Odds Mortality (90 day) 
 OR 95% CI OR 95% CI p-value 
Primary versus Secondary Diagnosis (M00) 
Primary 1.00 1.00 1.00 1.00  
Secondary 3.06 2.67, 3.51 2.10 1.79, 2.46 <0.001 
Sex 
Male 1.00 1.00 1.00 1.00  
Female 1.31 1.16, 1.49 0.87 0.75, 1.01 0.076 
Age (per five years) ‡ 
Age 1.45 1.41, 1.49 1.38 1.34, 1.42 <0.001 
Year of treatment (per five years) 
Year 1.08 1.02, 1.15 0.89 0.83, 0.96 0.002 
Charlson comorbidity index (per five units) ‡ 
Charlson index 1.52 1.48, 1.56 1.34 1.30, 1.39 <0.001 
Prior joint disease 
No 1.00 1.00 1.00 1.00  
Knee osteoarthritis 1.37 1.17, 1.61 0.72 0.60, 0.87 0.001 
Rheumatoid 
arthritis 1.52 1.21, 1.92 0.90 0.68, 1.18 0.437 
Index of multiple deprivation (quintile) 
1 = least 1.00 1.00 1.00 1.00 0.336 
2 0.94 0.76, 1.15 0.89 0.70, 1.13 0.872 
3 0.98 0.81, 1.20 1.02 0.81, 1.28 0.689 
4 0.91 0.74, 1.11 1.05 0.83, 1.33 0.172 
5 = most 0.72 0.59, 0.87 1.18 0.93, 1.51 0.336 
Rurality 
Urban 1.00 1.00 1.00 1.00  
Rural 1.22 1.05, 1.42 1.12 0.93, 1.34 0.227 
Ethnicity 
White 1.00 1.00 1.00 1.00  
Mixed 0.38 0.12, 1.19 1.03 0.28, 3.75 0.961 
Asian 0.62 0.42, 0.91 1.03 0.67, 1.59 0.875 
Black 0.39 0.22, 0.70 0.77 0.41, 1.45 0.417 
Other 0.53 0.21, 1.30 1.91 0.71, 5.18 0.201 
Diabetes ‡ 
No 1.00 1.00 1.00 1.00  
Yes 2.18 1.89, 2.51 1.54 1.31, 1.81 <0.001 
 
* adjusted by all variables in the table except diabetes (see below ‡); OR = odds ratio; CI = confidence interval; TKA = total or partial knee 
arthroplasty; ‡ Diabetes is included within the Charlson comorbidity index and therefore these colinear variables were not included together in 
the model. The main model reported in this table included the Charlson comorbidity index. The secondary adjusted model for diabetes included 
all the variables in the table except the Charlson comorbidity index: to show the association of the outcome with diabetes, independent from the 
other comorbidities recorded in the Charlson index. 
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TABLE 3:  
One-year adverse operative outcomes in all patients with at least one-year of follow-up (n=11,393) 
 1-year Arthrodesis 1-year Amputation 1-year Arthroplasty 
 n Outcome % (95% CI) n Outcome % (95% CI) n Outcome % (95% CI) 
Total 11,393 15 0.13% (0.07, 0.22) 11,393 46 0.40% (0.30, 0.54) 11,393 152 1.33% (1.13, 1.56) 
Male 7,333 10 0.14% (0.07, 0.25) 7,333 34 0.46% (0.32, 0.65) 7,333 97 1.32% (1.07, 1.61) 
Female 4,060 5 0.12% (0.04, 0.29) 4,060 12 0.30% (0.15, 0.52) 4,060 55 1.35% (1.02, 1.76) 
Age group (years) 
< 20 1,175 0 0.00% (0.00, 0.31) 1,175 0 0.00% (0.00, 0.31) 1,175 0 0.00% (0.00, 0.31) 
20 - 39 1,682 1 0.06% (0.00, 0.33) 1,682 2 0.12% (0.01, 0.43) 1,682 1 0.06% (0.00, 0.33) 
40 - 59 2,456 3 0.12% (0.03, 0.36) 2,456 10 0.41% (0.20, 0.75) 2,456 33 1.34% (0.93, 1.88) 
60 - 79 3,897 8 0.21% (0.09, 0.40) 3,897 28 0.72% (0.48, 1.04) 3,897 105 2.69% (2.21, 3.25) 
80 + 2,183 3 0.14% (0.03, 0.40) 2,183 6 0.27% (0.10, 0.60) 2,183 13 0.60% (0.32, 1.02) 
Modified Charlson comorbidity index 
0 6,125 9 0.15% (0.07, 0.28) 6,125 5 0.08% (0.03, 0.19) 6,125 86 1.40% (1.12, 1.73) 
1 - 15 3,584 3 0.08% (0.02, 0.24) 3,584 23 0.64% (0.41, 0.96) 3,584 60 1.67% (1.28, 2.15) 
16 - 30 1,254 3 0.24% (0.05, 0.70) 1,254 13 1.04% (0.55, 1.77) 1,254 5 0.40% (0.13, 0.93) 
31 - 50 430 0 0.00% (0.00, 0.85) 430 5 1.16% (0.38, 2.69) 430 1 0.23% (0.01, 1.29) 
Prior joint disease 
No 8,934 10 0.11% (0.05, 0.21) 8,934 37 0.41% (0.29, 0.57) 8,934 77 0.86% (0.68, 1.08) 
Knee osteoarthritis 1,904 5 0.26% (0.09, 0.61) 1,904 7 0.37% (0.15, 0.76) 1,904 62 3.26% (2.51, 4.16) 
Rheumatoid arthritis 716 0 0.00% (0.00, 0.51) 716 2 0.28% (0.03, 1.01) 716 22 3.07% (1.94, 4.62) 
Diabetes 
No 9,615 12 0.12% (0.06, 0.22) 9,615 24 0.25% (0.16, 0.37) 9,615 130 1.35% (1.13, 1.60) 
Yes 1,778 3 0.17% (0.03, 0.49) 1,778 22 1.24% (0.78, 1.87) 1,778 22 1.24% (0.78, 1.87) 
Index of multiple deprivation (quintiles) 
1 = least deprived 1,946 4 0.21% (0.06, 0.53) 1,946 5 0.26% (0.08, 0.60) 1,946 30 1.54% (1.04, 2.19) 
2 2,074 2 0.10% (0.01, 0.35) 2,074 10 0.48% (0.23, 0.88) 2,074 30 1.45% (0.98, 2.06) 
3 2,168 4 0.18% (0.05, 0.47) 2,168 9 0.42% (0.19, 0.79) 2,168 41 1.89% (1.36, 2.56) 
4 2,187 1 0.05% (0.00, 0.25) 2,187 5 0.23% (0.07, 0.53) 2,187 33 1.51% (1.04, 2.11) 
5 = most deprived 2,706 3 0.11% (0.02, 0.32) 2,706 17 0.63% (0.37, 1.00) 2,706 18 0.67% (0.39, 1.05) 
Missing          
Rurality 
Urban 8,891 10 0.11% (0.05, 0.21) 8,891 36 0.40% (0.28, 0.56) 8,891 102 1.15% (0.94, 1.39) 
Rural 2,238 4 0.18% (0.05, 0.46) 2,238 10 0.45% (0.21, 0.82) 2,238 50 2.23% (1.66, 2.93) 
Missing          
Ethnicity 
White 9,838 15 0.15% (0.09, 0.25) 9,838 45 0.46% (0.33, 0.61) 9,838 145 1.47% (1.25, 1.73) 
Mixed 74 0 0.00% (0.00, 4.86) 74 1 1.35% (0.03, 7.30) 74 0 0.00% (0.00, 4.86) 
Asian 440 0 0.00% (0.00, 0.83) 440 0 0.00% (0.00, 0.83) 440 2 0.45% (0.06, 1.63) 
Black 296 0 0.00% (0.00, 1.24) 296 0 0.00% (0.00, 1.24) 296 2 0.68% (0.08, 2.42) 
Other 90 0 0.00% (0.00, 4.02) 90 0 0.00% (0.00, 4.02) 90 1 1.11% (0.03, 6.04) 
Missing          
CI = confidence interval 
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TABLE 4:  
Hazard ratios (subsequent TKA within maximum of 20 years)  
 
 Unadjusted Risk Subsequent TKA Adjusted* Risk Subsequent TKA 
 HR 95% CI HR 95% CI p-value 
Sex 
Male 1.00 1.00 1.00 1.00  
Female 1.50 1.29, 1.75 1.12 0.96, 1.32 0.145 
Age (per five years) ‡ 
Age 1.15 1.13, 1.17 1.12 1.10, 1.15 <0.001 
Year of treatment (per five years) 
Year 1.13 1.04, 1.22 1.04 0.95, 1.13 0.390 
Charlson comorbidity index (per five units) ‡ 
Charlson index 0.98 0.93, 1.04 0.78 0.73, 0.84 <0.001 
Prior joint disease 
No 1.00 1.00 1.00 1.00  
Knee osteoarthritis 3.72 3.13, 4.41 2.50 2.09, 3.00 <0.001 
Rheumatoid arthritis 3.94 3.14, 4.95 3.73 2.92, 4.75 <0.001 
Index of multiple deprivation (quintile) 
1 = least 1.00 1.00 1.00 1.00  
2 1.03 0.81, 1.31 0.99 0.78, 1.26 0.936 
3 1.16 0.92, 1.46 1.16 0.92, 1.47 0.216 
4 0.98 0.77, 1.25 1.09 0.85, 1.39 0.500 
5 = most 0.61 0.47, 0.78 0.80 0.61, 1.04 0.093 
Rurality 
Urban 1.00 1.00 1.00 1.00  
Rural 1.50 1.26, 1.78 1.18 0.98, 1.41 0.079 
Ethnicity 
White 1.00 1.00 1.00 1.00  
Mixed 0.93 0.39, 2.25 1.58 0.65, 3.84 0.309 
Asian 0.46 0.28, 0.77 0.61 0.36, 1.04 0.072 
Black 0.26 0.11, 0.57 0.39 0.17, 0.87 0.022 
Other 0.16 0.02, 1.12 0.29 0.04, 2.05 0.215 
Diabetes ‡ 
No 1.00 1.00 1.00 1.00  
Yes 1.04 0.83, 1.31 0.77 0.61, 0.98 0.032 
 
* adjusted by all variables in the table except diabetes (see below ‡); HR = hazard ratio; CI = confidence interval; TKA = total or partial knee 
arthroplasty; ‡ Diabetes is included within the Charlson comorbidity index and therefore these colinear variables were not included together in 
the model. The main model reported in this table included the Charlson comorbidity index. The secondary adjusted model for diabetes included 
all the variables in the table except the Charlson comorbidity index: to show the association of the outcome with diabetes, independent from the 




TABLE 5:  
Rates and relative risk of undergoing TKA with a history of previous septic knee washout (within prior 20 years) 
versus the general population (without a recorded history of previous septic knee washout) by age in 2016-17 
 
 Prior septic knee Without prior septic knee Relative Risk of Arthroplasty (Annual) 







95% CI RR 95% CI p-value 
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27.25 13.01, 57.09 <0.001 









10.56 6.59, 16.93 <0.001 



















2.59 1.86, 3.62 <0.001 









6.14 4.95, 7.62 <0.001 
 
















FIGURE 2: Survival curve (not undergoing knee arthroplasty), by age group † 
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